Ken Griffin Aim Immuno Tech Inc. Put Options Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AIM
# of Institutions
39Shares Held
5.22MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.44MShares$146,6590.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$41,8960.0% of portfolio
-
Geode Capital Management, LLC Boston, MA531KShares$31,8800.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny260KShares$15,6280.0% of portfolio
-
State Street Corp Boston, MA173KShares$10,3860.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $2.88M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...